Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis

被引：3
|
作者：
Wang, Mike [1 ,2 ]
Reynolds, Kerry L. [1 ,2 ]
Montazeri, Kamaneh [1 ,2 ]
Schaefer, Esperance A. [2 ,3 ]
Sullivan, Ryan J. [1 ,2 ]
Dougan, Michael [2 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Mass Gen Canc Ctr, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 22卷 / 07期
关键词：
D O I：
10.1016/j.cgh.2023.12.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1539 / 1541
页数：3
相关论文
共 50 条
  • [21] Severe immune-mediated Hepatitis on Checkpoint Inhibitor Therapy
    Kirsten, H.
    Ziemer, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 92 - 92
  • [22] Guselkumab for treating immune checkpoint inhibitor-induced psoriatic arthritis
    Takeda, Koichi
    Yanagitani, Noriko
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10) : 1479 - 1480
  • [23] Prediction and Prophylaxis of Immune Checkpoint Inhibitor-mediated Hepatitis
    Schilling, H. L.
    Hutchinson, J.
    Kronenberg, K.
    Riquelme, P.
    Wenzel, J.
    Glehr, G.
    Zeman, F.
    Evert, K.
    Schmiedel, M.
    Mickler, M.
    Drexler, K.
    Bitterer, F.
    Cordero, L.
    Beyer, L.
    Bach, C.
    Koestler, J.
    Burkhardt, R.
    Schlitt, H.
    Hellwig, D.
    Werner, J.
    Spang, R.
    Schmidt, B.
    Geissler, E.
    Haferkamp, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 6 - 6
  • [24] Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis
    Halsey, Taylor M.
    Thomas, Anusha S.
    Hayase, Tomo
    Ma, Weijie
    Abu-Sbeih, Hamzah
    Sun, Baohua
    Parra, Edwin Roger
    Jiang, Zhi-Dong
    DuPont, Herbert L.
    Sanchez, Christopher
    El-Himri, Rawan
    Brown, Alexandria
    Flores, Ivonne
    McDaniel, Lauren
    Turrubiates, Miriam Ortega
    Hensel, Matthew
    Pham, Dung
    Watowich, Stephanie S.
    Hayase, Eiko
    Chang, Chia-Chi
    Jenq, Robert R.
    Wang, Yinghong
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (700)
  • [25] Checkpoint Inhibitor-Related Immune Hepatitis and Subsequent Cirrhosis
    Chaudhary, Dhishna
    Azhar, Mishah
    Okpokpo, Enoemem M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1428 - S1428
  • [26] A Potential New Use for Tocilizumab: A Case of Refractory Checkpoint Inhibitor Hepatitis
    Lyles, Laine A.
    Farmer, Reagan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2082 - S2083
  • [27] Hepatitis C and tumors: immune checkpoint inhibitors safe and effective?
    Simon, Annika
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (02): : 156 - 158
  • [28] Refractory Immune Checkpoint Inhibitor-Associated Colitis: Case Report
    Aliyev, Nurlan
    Reif, Meagan S.
    Chaisidhivej, Natapat
    Yasmeh, Pauline
    Middleton, Jacob C.
    Bhat, Romana A.
    Jabak, Suha J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2069 - S2069
  • [29] Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis
    Klemm, Natasha
    Trasolini, Roberto
    Chahal, Daljeet
    Donnellan, Fergal
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [30] Predictors of steroid-refractory immune checkpoint inhibitor associated myocarditis
    Power, J.
    Meijers, W.
    Fenioux, C.
    Tamura, Y.
    Asnani, A.
    Alexandre, J.
    Cautela, J.
    Aras, M.
    Lehmann, L.
    Perl, M.
    Narezkina, A.
    Gilstrap, L.
    Ederhy, S.
    Moslehi, J.
    Salem, J.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3272 - 3272
12345